1. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial. Issue 16 (15th April 2021) Authors: Beissbarth, J.; Wilson, N.; Arrowsmith, B.; Binks, M.J.; Oguoma, V.M.; Lawrence, K.; Llewellyn, A.; Mulholland, E.K.; Santosham, M.; Morris, P.S.; Smith-Vaughan, H.C.; Cheng, A.C.; Leach, A.J. Journal: Vaccine Issue: Volume 39:Issue 16(2021) Page Start: 2264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗